PAX8 and renal cell carcinoma: The silencing of PAX8 leads to decreased proliferation in RCC cell lines [27], inducing apoptosis through a p53-dependent pathway, which involves caspase-3 activation and poly(ADP)ribose polymerase cleavage [41].